Eric Tran
Member of Scientific Advisory BoardDr. Eric Tran, Ph.D, serves as Member of Scientific Advisory Board of Turnstone Biologics Inc. since December 2021. He serves as Member of the Scientific Advisory Board at Turnstone Biologics Corp. He serves as Member of Scientific Advisory Board at PACT Pharma, Inc. and Genocea Biosciences, Inc. Dr. Tran is an expert in targeting mutated neoantigens using adoptive cell transfer (ACT) therapy. His studies have provided the most direct evidence that T cells targeting neoantigens can mediate tumor regression in patients with metastatic epithelial cancers. He carried out his postdoctoral research fellowship in Bethesda MD, at the National Cancer Institute of the National Institutes of Health, mentored by Dr. Steven A. Rosenberg, a pioneer and leader in human cancer immunotherapy. Dr. Tran earned his Ph.D. at the University of Victoria in British Columbia, Canada, and received postdoctoral training at the National Cancer Institute, National Institutes of Health under the direct mentorship of Dr. Steven A. Rosenberg, a leader and pioneer in human cancer immunotherapy.
Positions
- Company NameGenocea Biosciences, Inc.Stock CodeGNCAQPositionMember of Scientific Advisory Board
